Atropine but not alpha- or beta-adrenergic blockers exert effects on GLP-1(7-36)amide and insulin secretion in humans.

被引：0
|
作者：
Balks, H
Hoffmann, B
Holst, J
VonZurMuhlen, A
机构：
来源：
DIABETES | 1997年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：714 / 714
页数：1
相关论文
共 50 条
  • [41] Urinary excretion of glucagon-like peptide 1 (GLP-1) 7-36 amide in human type 2 (non-insulin-dependent) diabetes mellitus
    Lugari, R
    Ugolotti, D
    Dei Cas, A
    Barilli, AL
    Iotti, M
    Marani, B
    Orlandini, A
    Gnudi, A
    Zandomeneghi, R
    HORMONE AND METABOLIC RESEARCH, 2001, 33 (09) : 568 - 571
  • [42] Expression of glucagon-like peptide-1 (GLP-1) receptor and the effect of GLP-1-(7-36) amide on insulin release by pancreatic islets during rat ontogenic development
    García-Flores, M
    Zueco, JA
    Alvarez, E
    Blázquez, E
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (03): : 514 - 520
  • [43] GS-ALPHA MEDIATES STIMULATION OF RAT PARIETAL-CELLS IN RESPONSE TO GLUCAGON-LIKE PEPTIDE-1 (GLP-1) (7-36) AMIDE
    SCHMIDTLER, J
    DEHNE, K
    SCHUSDZIARRA, V
    CLASSEN, M
    SCHEPP, W
    REGULATORY PEPTIDES, 1992, 40 (02) : 245 - 245
  • [44] Effects of GLP-1-(7-36)NH2, GLP-1-(7-37), and GLP-1-(9-36)NH2 on intravenous glucose tolerance and glucose-induced insulin secretion in healthy humans
    Vahl, TP
    Paty, BW
    Fuller, BD
    Prigeon, RL
    D'Alessio, DA
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (04): : 1772 - 1779
  • [45] EGF AND TGF-ALPHA INHIBIT THE PARIETAL-CELL RESPONSE TO GLP-1 (7-36) AMIDE VIA A PERTUSSIS TOXIN-SENSITIVE MECHANISM
    SCHMIDTLER, J
    DEHNE, K
    SCHUSDZIARRA, V
    CLASSEN, M
    SCHEPP, W
    REGULATORY PEPTIDES, 1992, 40 (02) : 245 - 245
  • [46] Oral L-glutamine increases active GLP-1 (7-36) amide secretion and improves glycemic control in stretpozotocin-nicotinamide induced diabetic rats
    Badole, Sachin L.
    Bagul, Pranita P.
    Mahamuni, Sagar P.
    Khose, Rekha D.
    Joshi, Anuja C.
    Jangam, Ganesh B.
    Ghule, Arvindkumar E.
    Raut, Chandrashekhar G.
    Khedkar, Vijay M.
    Coutinho, Evans C.
    CHEMICO-BIOLOGICAL INTERACTIONS, 2013, 203 (02) : 530 - 541
  • [47] Comparative Effects of the Endogenous Agonist Glucagon-Like Peptide-1 (GLP-1)-(7-36) Amide and the Small-Molecule Ago-Allosteric Agent "Compound 2" at the GLP-1 Receptor
    Coopman, Karen
    Huang, Yan
    Johnston, Neil
    Bradley, Sophie J.
    Wilkinson, Graeme F.
    Willars, Gary B.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 334 (03): : 795 - 808
  • [48] Effect of glucagon on carbohydrate-mediated secretion of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-36 amide) (GLP-1)
    Ranganath, L
    Schaper, F
    Gama, R
    Morgan, L
    Wright, J
    Teale, D
    Marks, V
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 1999, 15 (06) : 390 - 394
  • [49] PYROGLUTAMYL-PHENYLALANINE-PROLINE AMIDE (EFP) INHIBITS THYROTROPIN-RELEASING-HORMONE (TRH) STIMULATED BUT NOT GLP-1(7-36)AMIDE, ARGININE, OR GLIBENCLAMIDE STIMULATED INSULIN-SECRETION IN HIT-T15 CELLS
    KULKARNI, RN
    HAQUE, M
    SMITH, DM
    GHATEI, MA
    BLOOM, SR
    REGULATORY PEPTIDES, 1994, 51 (03) : 299 - 299
  • [50] Gastric emptying glucose responses, and insulin secretion after a liquid test meal: Effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients
    Willms, B
    Werner, J
    Holst, JJ
    Orskov, C
    Creutzfeldt, W
    Nauck, MA
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (01): : 327 - 332
12345